Standard BioTools Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.12 | -$0.11 | -$0.11 |
| Q2 2024 | 1 | -$0.09 | -$0.08 | -$0.08 |
| Q3 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2024 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q1 2025 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q2 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2025 | 1 | -$0.05 | -$0.04 | -$0.05 |
| Q4 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
Standard BioTools Inc. Earnings Date And Information
Standard BioTools Inc. last posted its earnings results on Wednesday, October 30th, 2024. The company reported $-0.05 earnings per share for the quarter, topping analysts' consensus estimates of $-0.08 by $0.03. The company had revenue of 44.97 M for the quarter and had revenue of 106.34 M for the year. Standard BioTools Inc. has generated $-1 earnings per share over the last year ($-0.94 diluted earnings per share) and currently has a price-to-earnings ratio of -6.41. Standard BioTools Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2025 based on prior year's report dates.
Standard BioTools Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | -$0.07 | $41.00 M | $44.97 M | ||
| 08/06/2024 | Q2 2024 | -$0.12 | $48.25 M | $37.21 M | ||
| 05/09/2024 | Q1 2024 | -$0.11 | $45.54 M | |||
| 04/26/2024 | Q4 2023 | -$0.25 | $28.19 M | |||
| 11/07/2023 | Q3 2023 | -$0.12 | -$0.27 | -0.15 | $23.60 M | $25.37 M |
| 08/08/2023 | Q2 2023 | -$0.21 | -$0.22 | -0.01 | $24.20 M | $27.67 M |
| 05/09/2023 | Q1 2023 | -$0.21 | $25.12 M | |||
| 03/14/2023 | Q4 2022 | -$0.26 | $27.02 M | |||
| 11/09/2022 | Q3 2022 | -$0.37 | $30.95 M | $25.65 M | ||
| 08/09/2022 | Q2 2022 | -$0.82 | $29.78 M | $18.78 M | ||
| 05/09/2022 | Q1 2022 | -$0.99 | $26.50 M | |||
| 03/07/2022 | Q4 2021 | -$0.12 | $38.27 M | |||
| 11/08/2021 | Q3 2021 | -$0.18 | $30.00 M | $28.50 M | ||
| 08/06/2021 | Q2 2021 | -$0.23 | $30.99 M | $31.02 M | ||
| 05/07/2021 | Q1 2021 | -$0.25 | $32.79 M | |||
| 02/25/2021 | Q4 2020 | -$0.24 | $44.61 M | |||
| 11/06/2020 | Q3 2020 | -$0.08 | $32.47 M | $39.86 M | ||
| 08/07/2020 | Q2 2020 | -$0.18 | $19.07 M | $26.06 M | ||
| 05/11/2020 | Q1 2020 | -$0.23 | $27.62 M | |||
| 02/27/2020 | Q4 2019 | -$0.18 | $32.44 M |
Standard BioTools Inc. Earnings: Frequently Asked Questions
-
When is Standard BioTools Inc.'s earnings date?
Standard BioTools Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2025 based off last year's report dates.
-
Did Standard BioTools Inc. beat their earnings estimates last quarter?
In the previous quarter, Standard BioTools Inc. (:LAB) reported $-0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.08 by $0.03.
-
How can I listen to Standard BioTools Inc.'s earnings conference call?
The conference call for Standard BioTools Inc.'s latest earnings report can be listened to online.
-
How can I read Standard BioTools Inc.'s conference call transcript?
The conference call transcript for Standard BioTools Inc.'s latest earnings report can be read online.
-
How much revenue does Standard BioTools Inc. generate each year?
Standard BioTools Inc. (:LAB) has a recorded annual revenue of $106.34 M.
-
How much profit does Standard BioTools Inc. generate each year?
Standard BioTools Inc. (:LAB) has a recorded net income of $106.34 M. Standard BioTools Inc. has generated $-0.94 earnings per share over the last four quarters.
-
What is Standard BioTools Inc.'s price-to-earnings ratio?
Standard BioTools Inc. (:LAB) has a price-to-earnings ratio of -6.41 and price/earnings-to-growth ratio is -0.24.
